Portal de Periódicos da CAPES

Treatment of patients with keratoconjunctivitis sicca with Optive: results of a multicenter, open-label observational study in Germany.

2009; National Institutes of Health; Volume: 3; Linguagem: Inglês

Thomas Kaercher, P. Buchholz, Friedemann Kimmich,

Glaucoma and retinal disorders

To evaluate the efficacy and tolerability of Optive, a new dry eye product containing sodium carboxymethylcellulose (0.5%) and glycerol (0.9%), in patients with keratoconjunctivitis sicca (KCS).